Physician profile
Krishan Singh
NPI 1609491604
$10,195.40
in general payments reported to CMS, 2019-2025
29 companies · $729 in 2025
The $729 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $422 · 2021: $2,314 · 2022: $4,177 · 2023: $1,858 · 2024: $695 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,083 · Travel and Lodging: $805 · Education: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,082.50 |
| Travel and Lodging | $805.21 |
| Education | $394.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,950.33 | 2020-2025 | Prostep, Allomatrix, Hoffmann |
| Wardlow Enterprises | $1,200.00 | 2021 | |
| Medical Device Business Services, INC. | $896.98 | 2020-2023 | |
| Kerecis Limited | $319.78 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $317.84 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $257.95 | 2020-2021 | |
| Smith+Nephew, INC. | $197.88 | 2023-2025 | Stravix Pl, Grafix Pl, Grafix Xc |
| Treace Medical Concepts, INC. | $121.79 | 2025 | |
| Sanara Medtech INC. | $121.78 | 2021-2023 | Celleraterx |
| Surgenex LLC | $93.86 | 2025 | Renograft, Pellograft, Surmatrix |
| Organogenesis INC. | $82.50 | 2021 | |
| Oak Med, INC. | $69.51 | 2024 | |
| Highridge Medical LLC | $67.31 | 2024-2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Ebi Osteogen Implantable Bone Growth Stimulator |
| Mimedx Group, INC. | $63.88 | 2024-2025 | |
| Zimvie INC. | $63.68 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lightbody Medical Technologies INC | $51.58 | 2024 | |
| Paratek Pharmaceuticals, INC. | $43.23 | 2024 | Nuzyra |
| Orthofix Medical, INC. | $33.65 | 2024 | Physio-Stim, Accelstim |
| Solventum Corporation | $31.40 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Ebi, LLC | $31.30 | 2025 | Biomet Ebi Bone Healing System, Ebi Osteogen Implantable Bone Growth Stimulator |
| Depuy Synthes Sales INC. | $24.01 | 2024 | Hammerlock |
| Baudax Bio INC. | $22.72 | 2021 | |
| Linvatec Corporation | $22.10 | 2025 | Biobrace 23mm |
| Baxter Healthcare | $20.37 | 2025 | Floseal |
| Polynovo North America LLC | $19.21 | 2024 | Novosorb Btm |
| Janssen Pharmaceuticals, INC | $18.59 | 2023 | Xarelto |
| Acera Surgical, INC. | $17.67 | 2021 | |
| Medwest Associates | $17.52 | 2023 | |
| Lifenet Health | $16.98 | 2024 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishan Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.